Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer
AUTOR(ES)
Halabi, Susan
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2698015Documentos Relacionados
- Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study
- Issues in Using Progression-Free Survival When Evaluating Oncology Products
- Inhibition of constitutive and cxc-chemokine-induced NF-κB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells
- Interim interleukin 6 levels correlate with progression-free survival in patients with classic Hodgkin's disease: a pilot study
- Comparison of Power Between Randomized Discontinuation Design and Upfront Randomization Design on Progression-Free Survival